| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/12/2002 | WO2000077236A3 Methods for enhancing the production of cytokines in cell cultur e |
| 09/12/2002 | WO2000077182A9 Nucleic acid fragment and vector containing halogenase and method for the halogenation of chemical compounds |
| 09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/12/2002 | WO2000069901A3 Proteins with insulin-like activity useful in the treatment of diabetes |
| 09/12/2002 | WO2000067792A9 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 09/12/2002 | WO2000063435A3 Method of identifying toxic agents using differential gene expression |
| 09/12/2002 | US20020129405 Particle-mediated conifer transformation |
| 09/12/2002 | US20020129401 Nucleotide sequences coding enzymatic protein for use in textile and wood treatment |
| 09/12/2002 | US20020129398 Transfection, storage and transfer of male germ cells for generation of trangenic species |
| 09/12/2002 | US20020129395 Compositions to identify swine genetically resistant to F18 E. coli associated diseases |
| 09/12/2002 | US20020129394 Method for producing cloned bovines from cells of a bovine intramuscular preadipocyte cell line |
| 09/12/2002 | US20020129393 Expression vector for use in generating genetically engineering animal for use as tool in generating preferential proteins |
| 09/12/2002 | US20020129391 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/12/2002 | US20020129388 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis |
| 09/12/2002 | US20020129385 Medthods for improving long-term memory storage and retrieval |
| 09/12/2002 | US20020128724 Tissue graft |
| 09/12/2002 | US20020128464 Nucleotide sequences coding enzymatic polypeptide for use in generating geetically engineered herbicide sensitive plants |
| 09/12/2002 | US20020128459 Physiologically active protein originating in mammals |
| 09/12/2002 | US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections |
| 09/12/2002 | US20020128436 Therapeutic composition for use in the treatment of autoimune and rheumatic diseases |
| 09/12/2002 | US20020128346 Cell growth substrate polymer that is obtainable by copolymerizing a sulfo-containing monomer with a nonsulfo-containing monomer, optionally with a photoinitiator; especially photopolymerizing |
| 09/12/2002 | US20020128221 Glycosyltransferase vectors for treating cancer |
| 09/12/2002 | US20020128216 Antisense oligonucleotides and peptide nucleic acids for treating asthma or an eosinophilic syndrome |
| 09/12/2002 | US20020128200 Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals |
| 09/12/2002 | US20020128193 Retro-inverso prosaposin-derived peptides and use thereof |
| 09/12/2002 | US20020128192 Insecticides against coleopteran insects including red flour beetle larvae and Japanese beetle larvae (Popillia japonica); transgenic plants having genes encoding crystal protein or peptide; immunodetection kits |
| 09/12/2002 | US20020127721 Polypeptide for use in the treatment of cancer or genetic disorder |
| 09/12/2002 | US20020127719 Xenograft heart valves |
| 09/12/2002 | US20020127718 Maturation of dendritic cells by recombinant heat shock protein 70 |
| 09/12/2002 | US20020127717 Preparation of replicating macrophages and use in diagnosis and therapy |
| 09/12/2002 | US20020127716 Isolating preferential cells for use in the treatment of nervous system damage; isolate preferential cells, incubate with animal growth regulators, propagate, recover cells |
| 09/12/2002 | US20020127715 Adjusting gene expression in preferential cells; obtain pluripotent cells, transform, monitor gene expression, compare to control, detect adjustment in gene expression |
| 09/12/2002 | US20020127713 Specific tolerance in transplantation |
| 09/12/2002 | US20020127711 Process for ex vivo formation of mammalian bone and uses thereof |
| 09/12/2002 | US20020127696 Nucleotide sequences coding polypeptides for use in the generation of preferential mucopolysaccharides |
| 09/12/2002 | US20020127694 2786, a novel human aminopeptidase |
| 09/12/2002 | US20020127689 Novel human galectins |
| 09/12/2002 | US20020127688 Detecting modulators of enzymes associated with transcriptional activities; obtain cells, incubate with modulators, monitor adjustment in enzyme activities |
| 09/12/2002 | US20020127687 Genome DNA of bacterial symbiont of aphids |
| 09/12/2002 | US20020127679 Used in industrial production of (S)-4-halo-3-hydroxybutyrate ester |
| 09/12/2002 | US20020127676 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/12/2002 | US20020127668 Polypeptide for use in the diagnosis and treatment of cancer, nervous system and vessicular transport disorders |
| 09/12/2002 | US20020127653 Hematopoietic signaling factor |
| 09/12/2002 | US20020127648 Novel human C5a-like receptor |
| 09/12/2002 | US20020127647 ATP-binding cassette transporter-like molecules and uses thereof |
| 09/12/2002 | US20020127646 CD38 modulated chemotaxis |
| 09/12/2002 | US20020127644 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/12/2002 | US20020127643 Nucleotide sequences coding membrane proteins for use in human therapeutics and diagnostics |
| 09/12/2002 | US20020127638 Human metabotropic glutamate receptor 7 subtypes |
| 09/12/2002 | US20020127634 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 09/12/2002 | US20020127621 KUZ, a novel family of metalloproteases |
| 09/12/2002 | US20020127616 Prenatal diagnostic methods |
| 09/12/2002 | US20020127611 Detecting preferential water treatment polymer; generate antibody, incubate with water sample, monitor for the presence of preferential polymer |
| 09/12/2002 | US20020127601 Detecting modulators of g-protein coupled receptor activity; obtain cell containing g-protein coupled receptor pathway, incubate with modulator, determine quantative and qualitative effect of modulator on receptor |
| 09/12/2002 | US20020127600 Uncoupling protein for use in the treatment of body weight defects |
| 09/12/2002 | US20020127596 murF2 |
| 09/12/2002 | US20020127595 Endostatin; for use as a contraceptive and in cancer treatment |
| 09/12/2002 | US20020127584 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/12/2002 | US20020127582 Generating adenovirus-associated vector; obtain cells, transform with expression vector, propagate, recover transformed cells, propagate and recover vectors |
| 09/12/2002 | US20020127576 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of cancer, nervous system and blood disorders |
| 09/12/2002 | US20020127573 Diagnosing preferential dermatitis in humans; obtain cells, recover nucleotide sequences, screen for gene coding cytokines, monitor expression of cytokine, amplfied cytokine concentration indicates dermatitis |
| 09/12/2002 | US20020127564 Monitoring modulators of phenotypic expression in mammalian cells; obtain cell, transform, screen transformed cells for preferential phenotype |
| 09/12/2002 | US20020127558 Genetic polymorphism of MxA protein and use thereof |
| 09/12/2002 | US20020127553 Apoptin-associating protein |
| 09/12/2002 | US20020127540 Detecting modulators of bone morphogenic activities; obtain cells, incubate with modulator, monitor expression of reporter molecules, compare to control |
| 09/12/2002 | US20020127535 Application of reversible crosslinking and co-treatment in stabilization and viral inactivation of erythrocytes |
| 09/12/2002 | US20020127235 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/12/2002 | US20020127231 Extracellular domains of a heterodimeric protein operatively linked to immunoglobulin heavy and light chain polypeptides |
| 09/12/2002 | US20020127227 Antagonist monoclonal antibodies (mAb) that bind to the RHAMM (receptor for hyaluronic acid mediated motility) receptor; useful for preventing proliferative disease states in a mammal |
| 09/12/2002 | US20020127222 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 09/12/2002 | US20020127221 Urocortin proteins and uses thereof |
| 09/12/2002 | US20020127217 A polynucleotides which identify and encode Phosphatidylinositol 4,5-bisphosphate 5-phosphatase (polypeptide) |
| 09/12/2002 | US20020127210 Transplants for myocardial scars |
| 09/12/2002 | US20020127208 Method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease |
| 09/12/2002 | US20020127204 Improvements in or relating to protection against intracellular infection |
| 09/12/2002 | US20020124855 Method of providing a dynamic cellular cardiac support |
| 09/12/2002 | DE10112360A1 Transformierte Blutzellen und ihre Verwendung zum Wirkstoffscreening Transformed blood cells and their use for drug screening |
| 09/12/2002 | DE10109855A1 Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptide of a p53 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109854A1 Polypeptide eines hdm2-Protein spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptides of hdm2 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109813A1 Tumor-Peptidantigen aus humanem mdm2 Proto-Onkogen Tumor antigen peptide from human MDM2 proto-oncogene |
| 09/12/2002 | DE10109166A1 Avilamycin-Derivate Avilamycin derivatives |
| 09/12/2002 | DE10109136A1 Using inhibitor of thrombospondin-1 interaction for promoting wound healing, also for treating living skin replacements, inhibits apoptosis of wound-repair cells |
| 09/12/2002 | CA2743731A1 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 09/12/2002 | CA2445018A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | CA2445013A1 Polypeptides of an hdm2 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2445004A1 Polypeptides of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2440092A1 Protein c variants |
| 09/12/2002 | CA2439986A1 Cell visual characteristic-modifying sequences |
| 09/12/2002 | CA2439941A1 Secreted proteins |
| 09/12/2002 | CA2439899A1 Improved skin substitutes and uses thereof |
| 09/12/2002 | CA2439636A1 Mouse cytokine receptor |
| 09/12/2002 | CA2439628A1 Vaccine |
| 09/12/2002 | CA2439594A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | CA2439504A1 Compositions and methods relating to osteoarthritis |
| 09/12/2002 | CA2439205A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439203A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439200A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439197A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439196A1 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | CA2439195A1 Nuclear hormone receptor ligand binding domain |